Arthri-Mend Maximum Strength Cetyl Myristoleate - Cetyl Myristoleate was developed by Harry Diehl while employed by the National Institute of Arthritis, a researcher at the National Institute of Health. It has been hailed by some medical researchers as one of the most important discoveries of this century in treating joint and cartilage problems. Unlike other joint and cartilage treatments, Arthri-Mend works to correct the problem at the source of joint and cartilage conditions, rather than only treating the symptoms.
This product is supported by several clinical trials, including that conducted by Dr. H. Siemindi, Joint European Hospital Studies Program. This study showed an 87.3% positive response to the use of the active ingredient in Arthri-Mend. Joint and cartridge rehabilitation at the immune system level Anti-inflammatory effects. When used for support in a randomized clinical trial, cetyl myristoleate achieved 87.3% response (88.2% improvement) when taken with glucosamine, sea cucumber, and hydrolyzed cartridge (an impressive 63.3% when taken without).
Directions: Highly effective in the relief of joint and cartilage problems. It is recommended that it be used in conjunction with Glucosamine. It is believed that Glucosamine repairs the damage to cartilage whereas Cetyl Myristoleate stops the damage from occurring.
Ingredients: Cetyl Myristoleate 30%. COMPLETE FORMULA: Cetyl Myristoleate, Synergistic Essential Fatty Acid Esther, Cetyl Myristate, Olive Oil, Salmon Oil, Lecithin, Cetyl Palmitoleate, Cetyle Laurate, Cetyl Palmitate, Cetyl Oleate.
|
